Commerical development of stem cell technology: lessons from the past, strategies for the future

Paul A. Martin, Catherine Coveney, Alison Kraft, Nik Brown, Philip Bath

Research output: Contribution to journalLiterature reviewpeer-review


This paper presents historical and contemporary survey data on the commercial development of stem cell technology from the 1990s to the present day. We describe the first wave of industrial investment in hematopoietic stem cells during the 1990s and contrast this with the more recent expansion of the sector. In particular, we explore the cell types used, diseases targeted and business models adopted by firms. We conclude, by arguing that the commercial prospects for stem cell technologies remain highly uncertain and that innovative public policies should be adopted to prevent 'market failure'.

Original languageEnglish
Pages (from-to)801-807
Number of pages7
Issue number6
Publication statusPublished - Nov 2006


  • firm strategies
  • industry
  • public policy
  • stem cells

Cite this